저온 플라즈마 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of cold plasma Market

The global cold plasma market size was valued at USD 161.7 million in 2025 and is projected to grow from USD 182.8 million in 2026 to USD 498.0 million by 2034, exhibiting a CAGR of 13.3% from 2026 to 2034. Europe dominated the global market with a 36.92% market share in 2025. Cold plasma technology enables pathogen inactivation, tissue microenvironment modulation, and surface or food decontamination without thermal damage. Its growing use in chronic wound care, dermatology, infection control, sterilization, and emerging medical applications is supporting market expansion.

Market Definition and Scope

Cold plasma refers to partially ionized gas generated at relatively low temperatures and used for biological, medical, and surface-treatment applications. In healthcare, approved systems are increasingly used for chronic wound management and dermatological treatments. The market is analyzed by product type, technology, application, end user, and geography.

Market Trends

The market is shifting toward portable, ergonomic, and clinic-friendly cold plasma systems that can be integrated into routine wound-care pathways. Growing clinical evidence, real-world studies, and technological improvements are strengthening adoption. Development of home-use devices is another emerging trend, enabling repeated treatment outside traditional hospital settings.

Market Dynamics

Market Driver - Rising Focus on Infection Prevention

Hospitals and clinics are increasingly prioritizing infection prevention and improved patient outcomes. Cold plasma can support pathogen reduction and wound-care management without relying solely on conventional approaches. Growing emphasis on faster healing, patient comfort, and reducing complications is encouraging healthcare providers to explore cold plasma technologies.

Market Restraint - Lack of Standardization

Differences in plasma energy sources, gas compositions, reactive species, exposure times, and device configurations make it difficult to establish uniform treatment protocols. Limited comparability across clinical studies and the need for stronger reproducible evidence can slow institutional adoption.

Market Opportunity - Development of Home-Based Devices

Home-based cold plasma instruments represent an important opportunity because chronic wound patients may require repeated treatment. Lightweight and simple devices can improve convenience and reduce the need for frequent clinical visits. In June 2025, hyped science GmbH announced PHLAS, a cold-plasma skincare technology designed for homecare use.

Market Challenge - Reimbursement and Clinical Integration

Uncertainty surrounding reimbursement and the need to integrate repeated treatment sessions into existing clinical workflows can limit adoption. Training requirements for physicians, nurses, wound-care specialists, and other staff also create implementation challenges.

Segmentation Analysis

By Product Type

The market is divided into cold plasma systems and accessories. Cold plasma systems dominated in 2025 because they represent the primary treatment platform used in hospitals, wound-care centers, and dermatology clinics. Accessories are projected to grow at a 15.8% CAGR, supported by increasing utilization of complete treatment systems.

By Technology

The market includes atmospheric pressure plasma jet, dielectric barrier discharge, and others. Atmospheric pressure plasma jet dominated and is expected to hold a 60.6% share in 2026, supported by bedside usability and suitability for repeated wound-care procedures. Dielectric barrier discharge is projected to grow at a 12.1% CAGR.

By Application

Applications include wound healing, infection control & sterilization, dermatology & aesthetic medicine, cancer, and others. Wound healing dominated and is expected to account for a 57.2% share in 2026, supported by demand for treatment of diabetic foot ulcers, pressure sores, venous ulcers, and post-surgical wounds. The cancer segment is projected to grow at a 13.5% CAGR.

By End User

The market is segmented into hospitals & specialty clinics, academic & research institutes, and others. Hospitals and specialty clinics dominated in 2025 due to established clinical infrastructure and high patient volumes. Academic and research institutes are projected to grow at a 13.8% CAGR as clinical research and technological development expand.

Regional Outlook

Europe dominated the market in 2025 with a market value of USD 59.7 million and is projected to reach USD 67.0 million in 2026 at a 12.5% CAGR. France, the U.K., and Germany are expected to reach USD 10.9 million, USD 15.2 million, and USD 8.9 million, respectively, in 2026.

North America maintained a substantial position with a market value of USD 52.7 million in 2025, while the U.S. is projected to reach USD 56.2 million in 2026. Infection prevention, wound prevalence, product launches, and technology investments support regional growth.

Asia Pacific is projected to be the fastest-growing region, reaching USD 38.7 million in 2026. China and India are estimated at USD 12.9 million and USD 8.6 million, respectively.

Latin America is projected to reach USD 10.5 million in 2026, while GCC within the Middle East & Africa is expected to reach USD 2.5 million.

Competitive Landscape

The competitive landscape includes terraplasma medical GmbH, ADTEC Plasma Technology Co., Ltd., Relyon Plasma GmbH, Neoplas Tools GmbH, PlasmaMed GmbH, Noxilizer, Enercon Industries, TOMI Environmental Solutions, Apyx Medical, and Europlasma. Companies are emphasizing regulatory approvals, clinical validation, portable technologies, collaborations, and expansion into wound-care and dermatology applications.

Investment Analysis and Opportunities

Investment opportunities are emerging in portable cold plasma systems, homecare technologies, wound-care applications, advanced plasma technologies, and clinical research. Funding and strategic partnerships are supporting product commercialization and geographical expansion.

New Product Development

Manufacturers are developing portable devices, homecare systems, advanced plasma jets, antimicrobial technologies, and treatment platforms designed for integration with routine wound-care workflows. These innovations aim to improve usability, treatment consistency, and patient access.

Key Industry Developments

Recent developments include Plasmacure raising USD 6.9 million in July 2025, relyon plasma and Viromed entering a strategic collaboration in December 2024, St. Antonius wound center receiving USD 2.1 million in October 2024 for Plasmacure research, Niterra partnering with and investing in Neoplas Med in June 2022, and ADTEC Plasma Technology launching PlasmaTacta in April 2022.

Report Coverage

The report covers 2025, 2026, and 2034 market size and forecast, market trends, drivers, restraints, opportunities, challenges, segmentation by product type, technology, application, and end user, regional analysis, competitive landscape, key companies, investment opportunities, new product development, and recent industry developments.

Conclusion

The global cold plasma market is expected to expand from USD 161.7 million in 2025 to USD 182.8 million in 2026 and USD 498.0 million by 2034. Rising infection-prevention requirements, chronic wound prevalence, portable technologies, clinical evidence, and home-based treatment opportunities will support market development. Innovation in atmospheric pressure plasma systems and expansion into wound healing, dermatology, sterilization, and emerging medical applications will remain important growth areas.

Segmentation By Product Type, Technology, Application, End-user, and Region

By Product Type

• Cold Plasma Systems
• Accessories

By Technology

• Atmospheric Pressure Plasma Jet
• Dielectric Barrier Discharge
• Others

By Application

• Wound Healing
• Infection Control & Sterilization
• Dermatology & Aesthetic Medicine
• Cancer
• Other

By End-user

• Hospitals & Specialty Clinics
• Academic & Research Institutes
• Others

By Region

• North America (By Product Type, Technology, Application, End-user, and Country)
  • U.S.
• By Product Type
  • Canada
• By Product Type
• Europe (By Product Type, Technology, Application, End-user, and Country/Sub-region)
  • Germany
• By Product Type
  • U.K.
• By Product Type
  • France
• By Product Type
  • Spain
• By Product Type
  • Italy
• By Product Type
  • Scandinavia
• By Product Type
  • Rest of Europe
• By Product Type
• Asia Pacific (By Product Type, Technology, Application, End-user, and Country/Sub-region)
  • China
• By Product Type
  • Japan
• By Product Type
  • India
• By Product Type
  • Australia
• By Product Type
  • Southeast Asia
• By Product Type
  • Rest of Asia Pacific
• By Product Type
• Latin America (By Product Type, Technology, Application, End-user, and Country/Sub-region)
  • Brazil
• By Product Type
  • Mexico
• By Product Type
  • Rest of Latin America
• By Product Type
• Middle East & Africa (By Product Type, Technology, Application, End-user, and Country/Sub-region)
  • GCC
• By Product Type
  • South Africa
• By Product Type
  • Rest of Middle East & Africa
• By Product Type

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2023/2024
• 4.2. Technological Advancements in Cold Plasma
• 4.3. New Product Launches, Key Players
• 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Cold Plasma Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Cold Plasma Systems
  • 5.1.2. Accessories
• 5.2. Market Analysis, Insights and Forecast - By Technology
  • 5.2.1. Atmospheric Pressure Plasma Jet
  • 5.2.2. Dielectric Barrier Discharge
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Wound Healing
  • 5.3.2. Infection Control & Sterilization
  • 5.3.3. Dermatology & Aesthetic Medicine
  • 5.3.4. Cancer
  • 5.3.5. Other
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Hospitals & Specialty Clinics
  • 5.4.2. Academic & Research Institutes
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Cold Plasma Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Cold Plasma Systems
  • 6.1.2. Accessories
• 6.2. Market Analysis, Insights and Forecast - By Technology
  • 6.2.1. Atmospheric Pressure Plasma Jet
  • 6.2.2. Dielectric Barrier Discharge
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Wound Healing
  • 6.3.2. Infection Control & Sterilization
  • 6.3.3. Dermatology & Aesthetic Medicine
  • 6.3.4. Cancer
  • 6.3.5. Other
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Hospitals & Specialty Clinics
  • 6.4.2. Academic & Research Institutes
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
    • 6.5.1.1. By Product Type
  • 6.5.2. Canada
    • 6.5.2.1. By Product Type

7. Europe Cold Plasma Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Cold Plasma Systems
  • 7.1.2. Accessories
• 7.2. Market Analysis, Insights and Forecast - By Technology
  • 7.2.1. Atmospheric Pressure Plasma Jet
  • 7.2.2. Dielectric Barrier Discharge
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Wound Healing
  • 7.3.2. Infection Control & Sterilization
  • 7.3.3. Dermatology & Aesthetic Medicine
  • 7.3.4. Cancer
  • 7.3.5. Other
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Hospitals & Specialty Clinics
  • 7.4.2. Academic & Research Institutes
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
    • 7.5.1.1. By Product Type
  • 7.5.2. Germany
    • 7.5.2.1. By Product Type
  • 7.5.3. France
    • 7.5.3.1. By Product Type
  • 7.5.4. Spain
    • 7.5.4.1. By Product Type
  • 7.5.5. Italy
    • 7.5.5.1. By Product Type
  • 7.5.6. Scandinavia
    • 7.5.6.1. By Product Type
  • 7.5.7. Rest of Europe
    • 7.5.7.1. By Product Type

8. Asia Pacific Cold Plasma Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Cold Plasma Systems
  • 8.1.2. Accessories
• 8.2. Market Analysis, Insights and Forecast - By Technology
  • 8.2.1. Atmospheric Pressure Plasma Jet
  • 8.2.2. Dielectric Barrier Discharge
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Wound Healing
  • 8.3.2. Infection Control & Sterilization
  • 8.3.3. Dermatology & Aesthetic Medicine
  • 8.3.4. Cancer
  • 8.3.5. Other
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Hospitals & Specialty Clinics
  • 8.4.2. Academic & Research Institutes
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
    • 8.5.1.1. By Product Type
  • 8.5.2. Australia
    • 8.5.2.1. By Product Type
  • 8.5.3. China
    • 8.5.3.1. By Product Type
  • 8.5.4. India
    • 8.5.4.1. By Product Type
  • 8.5.5. Southeast Asia
    • 8.5.5.1. By Product Type
  • 8.5.6. Rest of Asia Pacific
    • 8.5.6.1. By Product Type

9. Latin America Cold Plasma Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Cold Plasma Systems
  • 9.1.2. Accessories
• 9.2. Market Analysis, Insights and Forecast - By Technology
  • 9.2.1. Atmospheric Pressure Plasma Jet
  • 9.2.2. Dielectric Barrier Discharge
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Wound Healing
  • 9.3.2. Infection Control & Sterilization
  • 9.3.3. Dermatology & Aesthetic Medicine
  • 9.3.4. Cancer
  • 9.3.5. Other
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Hospitals & Specialty Clinics
  • 9.4.2. Academic & Research Institutes
  • 9.4.3. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
    • 9.5.1.1. By Product Type
  • 9.5.2. Mexico
    • 9.5.2.1. By Product Type
  • 9.5.3. Rest of Latin America
    • 9.5.3.1. By Product Type

10. Middle East & Africa Cold Plasma Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Cold Plasma Systems
  • 10.1.2. Accessories
• 10.2. Market Analysis, Insights and Forecast - By Technology
  • 10.2.1. Atmospheric Pressure Plasma Jet
  • 10.2.2. Dielectric Barrier Discharge
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Wound Healing
  • 10.3.2. Infection Control & Sterilization
  • 10.3.3. Dermatology & Aesthetic Medicine
  • 10.3.4. Cancer
  • 10.3.5. Other
• 10.4. Market Analysis, Insights and Forecast - By End-user
  • 10.4.1. Hospitals & Specialty Clinics
  • 10.4.2. Academic & Research Institutes
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. South Africa
    • 10.5.1.1. By Product Type
  • 10.5.2. GCC
    • 10.5.2.1. By Product Type
  • 10.5.3. Rest of Middle East & Africa
    • 10.5.3.1. By Product Type

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. terraplasma medical GmbH
  • 11.2.2. ADTEC Plasma Technology Co. Ltd.
  • 11.2.3. Relyon Plasma GmbH
  • 11.2.4. Neoplas Tools GmbH
  • 11.2.5. PlasmaMed GmbH
  • 11.2.6. Noxilizer, Inc.
  • 11.2.7. Enercon Industries Corporation
  • 11.2.8. TOMI Environmental Solutions, Inc.
  • 11.2.9. Apyx Medical Corporation
  • 11.2.10. Europlasma NV